Common polymorphisms (rs2241766 and rs1501299) in the ADIPOQ gene are not associated with hypertension susceptibility among the Chinese

Springer Science and Business Media LLC - Tập 39 - Trang 8771-8775 - 2012
Bo Xi1, Dan He1, Qijuan Wang1, Jian Xue1, Man Liu1, Jun Li1
1Department of Maternal and Child Health Care, School of Public Health, Shandong University, Jinan, China

Tóm tắt

The ADIPOQ gene has been implicated in the etiology of hypertension. However, the results have been inconsistent. In this study, a meta-analysis was performed to assess the associations of ADIPOQ polymorphisms with hypertension risk among the Chinese. Published literature from PubMed, CNKI and Wanfang Data were retrieved. Pooled odds ratio (OR) with 95 % confidence interval (CI) was calculated using fixed- or random-effects model. Six studies (1,812 cases and 2,631 controls) for rs2241766 polymorphism and four studies (1,449 cases and 2,175 controls) for rs1501299 polymorphism were identified. A marginally significant association was observed for rs2241766 polymorphism under recessive genetic model (GG vs. GT+TT: OR = 1.22, 95 % CI 1.01–1.48) and for rs1501299 polymorphism under heterogeneous co-dominant model (TG vs. GG: OR = 0.86, 95 % CI 0.75–0.99) and dominant model (TT+TG vs. GG: OR = 0.85, 95 % CI 0.74–0.98). In addition, under other genetic models, there was no significant association for rs2241766 polymorphism (GG vs. TT: OR = 1.20, 95 % CI 0.98–1.48; GT vs. TT: OR = 0.97, 95 % CI 0.85–1.10; GG+GT vs. TT: OR = 1.01, 95 % CI 0.90–1.15) and for rs1501299 polymorphism (TT vs. GG: OR = 0.82, 95 % CI 0.62–1.08; TT vs. TG+GG: OR = 0.87, 95 % CI 0.66–1.14). However, the associations above were not robust by sensitivity analysis. The present meta-analysis indicated the limited evidence of the significant associations between ADIPOQ gene polymorphisms and hypertension susceptibility among the Chinese.

Tài liệu tham khảo

Wu Y, Huxley R, Li L et al (2008) Prevalence, awareness, treatment, and control of hypertension in China: data from the China national nutrition and health survey 2002. Circulation 118:2679–2686 Harrison M, Maresso K, Broeckel U (2008) Genetic determinants of hypertension: an update. Curr Hypertens Rep 10:488–495 Kurtz TW, Spence MA (1993) Genetics of essential hypertension. Am J Med 94:77–84 Cnop M, Havel PJ, Utzschneider KM et al (2003) Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 4:459–469 Yang WS, Chuang LM (2006) Human genetics of adiponectin in the metabolic syndrome. J Mol Med 84:112–121 Chow WS, Cheung BM, Tso AW et al (2007) Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study. Hypertension 6:1455–1461 Yan WL, Chen SF, Huang JF et al (2006) Common SNPs of APM1 gene are not associated with hypertension or obesity in Chinese population. Biomed Environ Sci 19:179–184 Jeng JR (2007) Plasma adiponectin, T94G gene polymorphism and PAI-1 in patients with and without hypertension. Cardiology 107:30–37 Tang XM, Li JQ, Wu LR et al (2008) Relationship between adiponectin +45 nucleotide T/G polymorphism and essential hypertension. Tianjin Med J 36:762–764 Wang ZL, Xia B, Jiang L et al (2008) Association between adiponectin gene polymorphisms and hypertension. J New Med 18:25–29 Leu HB, Chung CM, Lin SJ et al (2011) Adiponectin gene polymorphism is selectively associated with the concomitant presence of metabolic syndrome and essential hypertension. PLoS One 6:e19999 DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188 Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748 Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101 Egger M, Davey Smith G, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634 Ong KL, Li M, Tso AW et al (2010) Association of genetic variants in the adiponectin gene with adiponectin level and hypertension in Hong Kong Chinese. Eur J Endocrinol 163:251–257 Zhang ZB, Yu LJ, Yang KJ et al (2011) Association between single nucleotide polymorphisms (SNPs) at the promoter of adiponectin gene and essential hypertension in Chinese Korean and Han of Yanbian region. Hereditas (Beijing) 33:54–59 Jia M, Qiao BM, Zhang Z et al (2008) Study on correlation of genetic polymorphism of adiponectin promoter and adiponectin level with hypertension and its complications. Chin J Lab Diagn 12:222–226 Boccia S, De Feo E, Gallì P et al (2010) A systematic review evaluating the methodological aspects of meta-analyses of genetic association studies in cancer research. Eur J Epidemiol 25:765–775 Zhao T, Zhao J (2011) Genetic effects of adiponectin on blood lipids and blood pressure. Clin Endocrinol (Oxf) 74:214–222 Yu Z, Han S, Cao X et al (2011) Genetic polymorphisms in adipokine genes and the risk of obesity: a systematic review and meta-analysis. Obesity (Silver Spring). doi:10.1038/oby.2011.148 Li Y, Li X, Shi L et al (2011) Association of Adiponectin SNP+45 and SNP+276 with type 2 diabetes in Han Chinese populations: a meta-analysis of 26 case–control studies. PLoS One 6:e19686